We are live on ! Find out more
HI

HBK Investments Portfolio holdings

AUM $10.2B
1-Year Est. Return 67.73%
This Fund
S&P 500
This Quarter Est. Return
+5.46%
1 Year Est. Return
+67.73%
3 Year Est. Return
+191.66%
5 Year Est. Return
+445.61%
10 Year Est. Return
+2,601.8%
AUM
$7.66B
AUM Growth
+$586M
Cap. Flow
-$144M
Cap. Flow %
-1.87%
Top 10 Hldgs %
54.23%
Holding
265
New
82
Increased
51
Reduced
40
Closed
50

Sector Composition

Rank Sector Weight
1 Energy 19.03%
2 Consumer Staples 9.38%
3 Healthcare 7.73%
4 Industrials 6.65%
5 Financials 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAGN
226
Magnera Corp
MAGN
$443M
-278,069
Closed -$5.05M
SFD
227
Smithfield Foods
SFD
$8.78B
-200,000
Closed -$4.08M
KRMN
228
Karman Holdings
KRMN
$6.81B
-100,000
Closed -$3.34M
AACBU
229
DELISTED
Artius II Acquisition Inc Units
AACBU
-500,000
Closed -$5.04M
SAIL
230
SailPoint Inc
SAIL
$10.3B
-350,000
Closed -$6.56M
LOKVU
231
DELISTED
Live Oak Acquisition Corp V Units
LOKVU
-400,000
Closed -$4.03M
CRWV
232
CoreWeave
CRWV
$47.6B
-150,000
Closed -$5.56M
LGF.B
233
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
-379,163
Closed -$3M
BERY
234
DELISTED
Berry Global Group, Inc.
BERY
-5,741,829
Closed -$401M
BECN
235
DELISTED
Beacon Roofing Supply, Inc.
BECN
-3,065,000
Closed -$379M
PYCR
236
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
-8,952,865
Closed -$201M
ITCI
237
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-4,385,000
Closed -$578M

Similar funds

HBK Investments's Q2 2025 Portfolio in Review

As of Q2 2025, HBK Investments held 265 positions worth $7.66B, up 8.3% from $7.08B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

HBK Investments's Q2 2025 filing shows 82 new, 51 increased, 40 reduced and 50 closed positions. Its largest new stake was Blueprint Medicines: 3,200,924 shares worth $410M. The largest sale was Intra-Cellular Therapies Inc., an estimated $578M.

By sector, the portfolio is most concentrated in Energy at 19% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Healthcare.

  • HBK Investments's largest Q2 2025 buy was Blueprint Medicines: 3,200,924 shares worth $410M.
  • HBK Investments added most to The AZEK Co in Q2 2025, an estimated $265M increase.
  • HBK Investments's biggest Q2 2025 reduction was Kellanova, cutting an estimated $107M.
  • HBK Investments fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $578M.
  • HBK Investments's ten largest holdings make up 54% of its $7.66B portfolio in Q2 2025.
  • HBK Investments opened 82 new positions and closed 50 in Q2 2025.
  • HBK Investments's portfolio value rose 8.3% quarter-over-quarter to $7.66B.

Based on HBK Investments's 13F filing for Q2 2025, filed 13 Aug 2025.